%2029-Dec-2006_files/image002.jpg)
|
Report Date : |
29th
December, 2006 |
IDENTIFICATION
DETAILS
|
Name : |
EGYPTIAN PHARMACISTS COMPANY SAE (EPC) |
|
|
|
|
Registered Office : |
5C, Square No. 1185, Sheraton Heliopolis Area, Cairo, Egypt |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Date of Incorporation : |
1996 |
|
|
|
|
Com. Reg. No.: |
296285, Cairo |
|
|
|
|
Legal Form : |
Societe Anonyme Egyptienne –
SAE (Egyptian Joint Stock Company) |
|
|
|
|
Line of Business : |
Manufacturing, bulk
packaging, distribution, import, export, and marketing of food supplements
and drugs. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$
250,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
Company
Name |
EGYPTIAN PHARMACISTS COMPANY SAE (EPC) |
|
Country
of Origin |
Egypt |
|
Legal
Form |
Egyptian Joint Stock Company |
|
Registration
Date |
1996 |
|
Commercial
Registration Number |
296285, Cairo |
|
Issued
Capital |
£E 4,500,000 |
|
Paid
up Capital |
£E 4,500,000 |
|
Total
Workforce |
50 |
|
Line
of Business |
Manufacturing, bulk
packaging, distribution, import, export, and marketing of food supplements
and drugs. |
|
Financial
Condition |
Fair |
|
Payments |
Nothing detrimental uncovered |
|
Operating
Trend |
Steady |
EGYPTIAN
PHARMACISTS COMPANY SAE (EPC)
Location : 5C, Square No. 1185, Sheraton Heliopolis Area
Town : Cairo
Country : Egypt
Telephone : (20-2) 2683567 / 2683569
Facsimile : (20-2) 2682172
Subject
operates from a medium sized suite of offices that are rented and located in
the Suburban Business Area of Cairo.
· Dr.
Ezzat Ali Ismail Chairman
· Dr.
Moustafa Abd El Salam Managing
Director
· Dr.
Moustafa Roushdy Director
· Dr.
Ahmed El Adawy Director
·
Dr. Diaa Youssef Ghobrial Director
·
Dr. Sherif Wally Director
·
Dr. Moustafa Gamgoum Director
·
Dr. Karam Kordy Abd El Fattah Director
·
Dr. Mohamed Essam Omar Director
· Dr.
Mohamed Adel Abu El Ela Director
· Khaled
Mohamed El Sheshaty Finance
Manager
· Mohamed
Abd El Khalek Accounts
Manager
Date of Establishment : 1996
Legal Form : Societe Anonyme Egyptienne – SAE (Egyptian Joint Stock Company)
Commercial Reg. No. : 296285, Cairo
Issued
Capital : £E 4,500,000
Paid
up Capital : £E 4,500,000
· Dr.
Ezzat Ali Ismail
· Dr.
Moustafa Abd El Salam
· Dr.
Moustafa Roushdy
· Dr.
Ahmed El Adawy
·
Dr. Diaa Youssef Ghobrial
·
Dr. Sherif Wally
·
Dr. Moustafa Gamgoum
·
Dr. Karam Kordy Abd El Fattah
·
Dr. Mohamed Essam Omar
· Dr.
Mohamed Adel Abu El Ela
· 350 Egyptian pharmacists
Note to the Legal Form
The Egyptian Company Law provides that the capital of a Societe Anonyme Egyptienne - SAE – should not be less than £E 500,000 if shares are offered to the public and £E 250,000 if not. If shares are offered to the public they are freely transferable, if not, transfer may be restricted. Liability of shareholders is limited.
Operations
: Engaged in the manufacturing, bulk
packaging, distribution, import, export, and marketing of food supplements and
drugs.
Import
Countries : Canada, United States of America, Italy,
Denmark, United Kingdom, Switzerland, and China.
Operating
Trend : Steady
Subject
has a workforce of 50 employees.
Companies
registered in Egypt are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
·
Banque
du Caire Barclays Internationale SAE
12, Midan El Sheikh Youssef Street
Garden City
PO Box: 110, Maglis El Shaab
Cairo
Tel :
(20-2) 3542195 / 3549415 / 3549422
Fax :
(20-2) 3552746
·
Banque
Misr
151 Mohamed Farid Street
Cairo
Tel :
(20-2) 3912711 / 3912106
Fax :
(20-2) 3919779
·
National
Societe General Bank
5 Champollion Street
Cairo
Tel :
(20-2) 7707777
Fax :
(20-2) 7707799
No
complaints regarding subject’s payments have been reported.
Opinion
on the credit figure of US$ 100,000
During
the course of this investigation nothing detrimental was uncovered regarding
subject’s operating history or the manner in which payments are fulfilled. As
such the company is considered to be a fair trade risk and the above credit
figure is within subject’s financial means.
Maximum
suggested credit figure: US$ 250,000
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial
base with the strongest capability for timely payment of interest and
principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No
caution needed for credit transaction. It has above average (strong)
capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are
regarded healthy. General unfavourable factors will not cause fatal effect.
Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors
carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of
interest and principal sums in default or expected to be in default upon
maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution
needed to be exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we
have no basis upon which to recommend credit dealings |
No Rating |
|